Z Li1, H Liao2, Z Tan1, D Mao1, Y Wu1, Y M Xiao1, S K Yang1, L Zhong1. 1. Department of Urology, SiChuan Cancer Hospital, Chengdu, China. 2. Department of Urology, SiChuan Cancer Hospital, Chengdu, China. liaohong131@163.com.
Abstract
PURPOSE: Micropapillary bladder cancer (MPBC) is a very rare and aggressive variant of urothelial carcinoma (UC). The aim of this study was to investigate the clinico-pathological characteristics, treatment, and prognosis of MPBC to improve the understanding of this invasive disease. METHODS: We reviewed the records of 6 patients with MPBC who were evaluated and treated at our hospital between 2009 and 2015, and additionally reviewed 38 cases reported in the literature. RESULTS: In 44 cases, 36 cases (81.8%) were male and 8 cases (18.2%) were female, with a male:female ratio of 4.5:1; the median age of the patients was 68 years (range 45-91 years). A majority (81.8%) of patients with cT1 above or with lymph node and distant metastasis (cT2N0 in 18.2%, cT3-4N0 in 13.6%, cTanyN+ in 43.2%, and cTanyM+ in 6.8%). There was a high grade in 70.5% of patients. Lymphovascular invasion (LVI) was present in 61.4% of patients, and LVI in cT2 was more common than in cT1 (71.4 vs 22.2%). 52.3% of patients were treated with radical cystectomy (RC). After a mean follow-up of 16.2 months, 77.3% of patients developed distant metastases, and 47.7% of patients died of the disease. The mean overall survival (OS) was 28.9 months and the median OS was 20 months, and the amount of micropapillary (MPP) is correlated inversely with prognosis. CONCLUSIONS: Micropapillary bladder cancer is a rare variant of UC associated with a poor prognosis, which often presents at an advanced stage with LVI and distant metastases. The optimal treatment strategy is early RC combined with chemotherapy.
PURPOSE:Micropapillary bladder cancer (MPBC) is a very rare and aggressive variant of urothelial carcinoma (UC). The aim of this study was to investigate the clinico-pathological characteristics, treatment, and prognosis of MPBC to improve the understanding of this invasive disease. METHODS: We reviewed the records of 6 patients with MPBC who were evaluated and treated at our hospital between 2009 and 2015, and additionally reviewed 38 cases reported in the literature. RESULTS: In 44 cases, 36 cases (81.8%) were male and 8 cases (18.2%) were female, with a male:female ratio of 4.5:1; the median age of the patients was 68 years (range 45-91 years). A majority (81.8%) of patients with cT1 above or with lymph node and distant metastasis (cT2N0 in 18.2%, cT3-4N0 in 13.6%, cTanyN+ in 43.2%, and cTanyM+ in 6.8%). There was a high grade in 70.5% of patients. Lymphovascular invasion (LVI) was present in 61.4% of patients, and LVI in cT2 was more common than in cT1 (71.4 vs 22.2%). 52.3% of patients were treated with radical cystectomy (RC). After a mean follow-up of 16.2 months, 77.3% of patients developed distant metastases, and 47.7% of patients died of the disease. The mean overall survival (OS) was 28.9 months and the median OS was 20 months, and the amount of micropapillary (MPP) is correlated inversely with prognosis. CONCLUSIONS:Micropapillary bladder cancer is a rare variant of UC associated with a poor prognosis, which often presents at an advanced stage with LVI and distant metastases. The optimal treatment strategy is early RC combined with chemotherapy.
Authors: Christina B Ching; Mahul B Amin; Raymond R Tubbs; Paul Elson; Eric Platt; Robert Dreicer; Amr Fergany; Donna E Hansel Journal: Mod Pathol Date: 2011-04-22 Impact factor: 7.842
Authors: Daniel L Willis; Mario I Fernandez; Rian J Dickstein; Sahil Parikh; Jay B Shah; Louis L Pisters; Charles C Guo; Samuel Henderson; Bogdan A Czerniak; H Barton Grossman; Colin P Dinney; Ashish M Kamat Journal: J Urol Date: 2014-09-22 Impact factor: 7.450
Authors: Wenping Li; Yu Liang; Michael T Deavers; Ashish M Kamat; Surena F Matin; Colin P Dinney; Bogdan Czerniak; Charles C Guo Journal: Am J Clin Pathol Date: 2014-12 Impact factor: 2.493
Authors: Adrian S Fairey; Siamak Daneshmand; Lina Wang; Anne Schuckman; Gary Lieskovsky; Hooman Djaladat; Jie Cai; Gus Miranda; Eila C Skinner Journal: Urol Oncol Date: 2013-03-14 Impact factor: 3.498
Authors: Ashish M Kamat; Jason R Gee; Colin P N Dinney; H Barton Grossman; David A Swanson; Randall E Millikan; Michelle A Detry; Tracy L Robinson; Louis L Pisters Journal: J Urol Date: 2006-03 Impact factor: 7.450
Authors: Donna E Hansel; Mahul B Amin; Eva Comperat; Richard J Cote; Ruth Knüchel; Rodolfo Montironi; Victor E Reuter; Mark S Soloway; Saleem A Umar; Theodorus H Van der Kwast Journal: Eur Urol Date: 2012-10-12 Impact factor: 20.096
Authors: Ashish M Kamat; Colin P N Dinney; Jason R Gee; H Barton Grossman; Arlene O Siefker-Radtke; Pheroze Tamboli; Michelle A Detry; Tracy L Robinson; Louis L Pisters Journal: Cancer Date: 2007-07-01 Impact factor: 6.860